Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.94 USD | -1.70% | -0.11% | +60.18% |
Jun. 05 | Harrow, Inc. Announces 52-Week Data from VEVYE ESSENCE-2 Open-Label Extension Study | CI |
Jun. 03 | Lake Street Raises Price Target on Harrow to $25 From $20, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+60.18% | 635M | |
+51.54% | 795B | |
-7.20% | 350B | |
+18.67% | 328B | |
+7.48% | 294B | |
+17.62% | 245B | |
+0.94% | 222B | |
+11.01% | 215B | |
+3.64% | 160B | |
-3.96% | 157B |
- Stock Market
- Equities
- HROW Stock
- News Harrow, Inc.
- B. Riley Securities Resumes Harrow Health at Buy with $17 Price Target, Says Well-Positioned to Maintain Robust Momentum